破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐

中金财经08-12

中国经济网北京8月12日讯凯赛生物(688065.SH)今日收报47.15元，跌幅3.32%。该股目前处于破发状态。　　凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人(主承销商)为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。　　上市首日，凯赛生物盘中最高价198元，为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2658276829?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-12 15:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658276829","market":"us","top_or_hot":-1,"title":"破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐","media":"中金财经","content":"<div>\n<p>中国经济网北京8月12日讯 凯赛生物(688065.SH)今日收报47.15元，跌幅3.32%。该股目前处于破发状态。\n\n　　凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人(主承销商)为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。\n\n　　上市首日，凯赛生物盘中最高价198元，为...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushijujiao/20260812/32332749.shtml\">网页链接</a>\n\n</div>\n","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-12 15:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://sc.stock.cnfol.com/gushijujiao/20260812/32332749.shtml><strong>中金财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中国经济网北京8月12日讯 凯赛生物(688065.SH)今日收报47.15元，跌幅3.32%。该股目前处于破发状态。\n\n　　凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人(主承销商)为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。\n\n　　上市首日，凯赛生物盘中最高价198元，为...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushijujiao/20260812/32332749.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0012","symbol_name":"证金概念","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260812/32332749.shtml","article_id":"2658276829","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2658276829","pubTimestamp":1786521304,"columns":[{"name":"A股","id":33,"label_key":"policyRegulatory"}],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"中国经济网北京8月12日讯 凯赛生物 今日收报47.15元，跌幅3.32%。该股目前处于破发状态。　　凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。　　凯赛生物于2025年3月28日披露《向特定对象发行A股股票发行情况报告书》。　　凯赛生物上述2次募集资金合计114.87亿元。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159982":"中证500","399300":"沪深300","600030":"中信证券","688065":"凯赛生物","BK0012":"证金概念","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","BK1564":"中资券商股","BK0028":"国家队","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0276":"资本市场","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","BK1516":"腾讯概念","LU1997245177.USD":"安联神洲A股基金","06030":"中信证券","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","IPOS":"Renaissance International IPO ETF","LU1720050803.USD":"安联全方位中国股票基金","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","BK1147":"投资银行业与经纪业","BK0196":"行业龙头","KCE":"SPDR KBW Capital Markets ETF","BK0208":"化学纤维","BK4127":"投资银行业与经纪业","LU1255011170.USD":"JPM CHINA A-SHARE OPPORTUNITIES \"A\" (USD) ACC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","FRHC":"Euronext CAC Health Care","REDS":"RPM Republican Senate ETF","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK1521":"挪威政府全球养老基金持仓","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU2580892862.HKD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (HKD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","BK0183":"MSCI概念","BK0188":"融资融券"},"translate_title":"Broken share Cathay Bio fell 3.32% A shares raised 11.5 billion IPO sponsored by CITIC Securities","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1.5,"399300":1.5,"600030":1.5,"688065":1.5,"REDS":1.5,"06030":1.5,"IPOS":1.5,"KCE":1.5,"FRHC":1.5},"content_text":"中国经济网北京8月12日讯 凯赛生物(688065.SH)今日收报47.15元，跌幅3.32%。该股目前处于破发状态。\n\n　　凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人(主承销商)为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。\n\n　　上市首日，凯赛生物盘中最高价198元，为该股上市以来最高价。\n\n　　凯赛生物首次公开发行股票募集资金总额556,062.10万元，募集资金净额为527,999.38万元。凯赛生物最终募集资金净额比原计划多58,108.38万元。凯赛生物于2020年8月11日披露的招股说明书显示，该公司拟募集资金469,891.00万元，计划分别用于凯赛(金乡)生物材料有限公司4万吨/年生物法癸二酸项目、生物基聚酰胺工程技术研究中心、凯赛(乌苏)生物技术有限公司年产3万吨长链二元酸和2万吨长链聚酰胺项目、补充流动资金。\n\n　　凯赛生物首次公开发行股票发行费用合计28,062.72万元(不含增值税金额)，其中，承销及保荐费用26,229.34万元。\n\n　　2022年7月12日，凯赛生物公告称，拟每10股派息(税前)4.5元，转增4股。股权登记日为2022年7月19日，除权除息日为2022年7月20日。\n\n　　资料显示，凯赛生物的实际控制人为 XIUCAI LIU(刘修才)、XIAOWEN MA、CHARLIE CHI LIU系美籍华人。\n\n　　凯赛生物于2025年3月28日披露《向特定对象发行A股股票发行情况报告书》。本次向特定对象发行的发行对象为控股股东上海曜修，系凯赛生物实际控制人XIUCAILIU(刘修才)家庭控制的企业，发行对象以人民币现金方式认购公司本次发行的股票，本次向特定对象发行构成关联交易。向特定对象发行股票的发行数量为137,911,755股，发行价格42.97元/股，募集资金总额人民币5,926,068,112.35元，募集资金净额人民币5,914,724,993.63元，扣除相关发行费用后的募集资金净额拟全部用于补充流动资金及偿还贷款。\n\n　　凯赛生物上述2次募集资金合计114.87亿元。\n\n　　(责任编辑：华青剑)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2658276829","isCrawlerRequest":true}